BioNTech Results Presentation Deck
BNT162 Manufacturing Update
Clinical supply
BioNTech to manufacture all drug substance for clinical supply at its GMP manufacturing facilities in Idar-Oberstein
and Mainz (both in Germany, partially 24/7 manufacturing)
Global pandemic and commercial supply capacities
Joint establishment of pandemic supply capacities at many network sites
BioNTech: At Idar-Oberstein and Mainz facilities in Germany
Pfizer: At least at three U.S. sites (Massachusetts, Michigan, Missouri) and at Puurs facility (Belgium)
BioN Tech and Pfizer working closely together (joint teams) on scale-up, supply chain and network planning
●
●
Drug product supply initially supported by BioNTech's formulation partner Polymun,
with Pfizer and BioNTech ramping up own capacity
8
●
●
BIONTECHView entire presentation